ABOUT ORIGIN LIFE SCIENCES, INC.
We are a clinical-stage biotechnology company with a proprietary patented high-energy plasma device that generates nitric oxide (NO) in the form of a plasma/NO stream and delivers it to targeted locations of the body. The stream can potentially be used for various therapeutic purposes, including as an anti-infective, anti-inflammatory and tissue-regenerative therapy for chronic wounds and skin and soft tissue infections and disorders.
The cornerstone of the plasma/NO therapy is our patented delivery platform named IonoJet™ which allows us to turn atmospheric air into a plasma/NO stream. Our technology is based on Nobel prize-winning research (13,14) and is designed to surpass current standards of care in efficacy, reduced side effects, and/or cost-effectiveness across a wide range of indications.
DEDICATED LEADERSHIP TEAM
Origin is supported by a dedicated management team and experienced board of directors with decades of experience in life sciences and in building value for shareholders.
They have had demonstrable success:
- Developing and marketing pharmaceuticals and medical devices, including wound-care products
- Administering hospitals and major healthcare delivery systems
- Growing and operating both private and publicly-traded businesses